Neurocrine Biosciences (NBIX) Stock Price & Financial Analysis
Neurocrine Biosciences Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Neurocrine Biosciences
What is the current stock price for NBIX?
As of the latest trading session, NBIX stock trades at $161.62. The 52-week range is $122.14–$169.57, with a day range of $159.32–$161.79.
What is the P/E ratio for NBIX?
Neurocrine Biosciences's trailing P/E ratio is 25.0, meaning investors pay $25.0 for every $1 of annual earnings. The forward P/E is 12.4, reflecting analyst expectations for future earnings. Neurocrine Biosciences operates in the Healthcare sector.
Does NBIX pay dividends?
Neurocrine Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for NBIX?
Based on 28 analysts, the consensus for NBIX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of NBIX?
Neurocrine Biosciences's market capitalization is $16.71B, classifying it as a large-cap company. Neurocrine Biosciences operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.